Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label crossover study of hydroxychloroquine in virologically controlled HIV infection
2007-007018-12Phase 4Active
- Sponsor
- Hospital Sant Joan de Reus
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydroxychloroquine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Hospital Sant Joan de Reus. Primary endpoints: Primary endpoint: reduction in MCP-1 and Primary endpoint: improvement in lipid profile. Started Jan 2008; status: active.
02
Drugs
hydroxychloroquine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-007018-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007018-12.